BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 25921216)

  • 21. Usefulness of tc-99m MIBI SPECT in predicting multidrug resistance gene expression levels in non-small cell lung cancer--a preliminary report.
    Aratani T; Narabayashi I; Komori T; Utsunomiya K; Sueyoshi K; Tachibana S; Sasaki S
    Ann Nucl Med; 2001 Aug; 15(4):313-9. PubMed ID: 11577755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression.
    Chang CS; Yang SS; Yeh HZ; Kao CH; Chen GH
    Hepatogastroenterology; 2004; 51(55):211-4. PubMed ID: 15011866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression.
    Saggiorato E; Angusti T; Rosas R; Martinese M; Finessi M; Arecco F; Trevisiol E; Bergero N; Puligheddu B; Volante M; Podio V; Papotti M; Orlandi F
    J Nucl Med; 2009 Nov; 50(11):1785-93. PubMed ID: 19837765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.
    Wang H; Chen XP; Qiu FZ
    World J Gastroenterol; 2004 May; 10(9):1281-5. PubMed ID: 15112342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
    Kao A; Shiun SC; Hsu NY; Sun SS; Lee CC; Lin CC
    Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
    Akgun A; Cok G; Karapolat I; Goksel T; Burak Z
    Ann Nucl Med; 2006 May; 20(4):269-75. PubMed ID: 16856570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression in pituitary adenoma.
    Kunishio K; Okada M; Matsumoto Y; Nagao S; Nishiyama Y
    J Med Invest; 2006 Aug; 53(3-4):285-91. PubMed ID: 16953066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis.
    Mohan HK; Miles KA
    J Nucl Med; 2009 Mar; 50(3):376-81. PubMed ID: 19223414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
    Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage IIIb or IV) with a higher T stage (> T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion.
    Hsu WH; Yen RF; Kao CH; Shiun SC; Hsu NY; Lin CC; Lee CC
    Oncology; 2002; 63(2):173-9. PubMed ID: 12239453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase (99m)Tc-MIBI SPECT/CT.
    Du C; Ying H; Zhou J; Jiang J; Liu C; Chen J; Wang X; Hu C
    Med Oncol; 2014 Feb; 31(2):833. PubMed ID: 24402323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technetium-99m-MIBI uptake in small cell lung cancer.
    Bom HS; Kim YC; Song HC; Min JJ; Kim JY; Park KO
    J Nucl Med; 1998 Jan; 39(1):91-4. PubMed ID: 9443743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
    Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
    J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.
    Martínez-Rodríguez I; Martínez-Amador N; de Arcocha-Torres M; Quirce R; Ortega-Nava F; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):93-8. PubMed ID: 24125595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response--a preliminary report.
    Kao CH; ChangLai SP; Chieng PU; Yen TC
    Cancer; 1998 Jul; 83(1):64-8. PubMed ID: 9655294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
    Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
    Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
    Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
    Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
    Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
    Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.